柳氮磺胺吡啶治疗类风湿关节炎的长期疗效 - Suppr

Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.

作者信息

Situnayake R D, McConkey B

出版信息

Drugs. 1986;32 Suppl 1:71-2. doi: 10.2165/00003495-198600321-00015.

DOI:10.2165/00003495-198600321-00015

PMID:2877857

Abstract

摘要

相似文献

Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.

Drugs. 1986;32 Suppl 1:71-2. doi: 10.2165/00003495-198600321-00015.

Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.

Drugs. 1986;32 Suppl 1:54-7. doi: 10.2165/00003495-198600321-00011.

Sulphasalazine in the long term management of rheumatoid arthritis.

Drugs. 1986;32 Suppl 1:73-6. doi: 10.2165/00003495-198600321-00016.

Sulphasalazine induced three-week syndrome.

J Clin Rheumatol. 2009 Sep;15(6):311-2. doi: 10.1097/RHU.0b013e3181bbbcea.

Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985.

Drugs. 1986;32 Suppl 1:1-80.

Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.

Drugs. 1986;32 Suppl 1:58. doi: 10.2165/00003495-198600321-00012.

History of the development of sulphasalazine in rheumatology.

Drugs. 1986;32 Suppl 1:12-7. doi: 10.2165/00003495-198600321-00004.

[Sulfasalazine-induced DRESS syndrome associated with Epstein Barr virus reactivation].

Therapie. 2013 Sep-Oct;68(5):321-3. doi: 10.2515/therapie/2013049. Epub 2013 Nov 14.

[New basic preparations with prolonged action in the treatment of rheumatoid arthritis].

Ter Arkh. 1987;59(4):80-3.

Rheumatoid arthritis: a pharmacologic overview.

Am Fam Physician. 1988 Mar;37(3):145-52.

引用本文的文献

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma.

Sci Rep. 2022 Dec 21;12(1):22077. doi: 10.1038/s41598-022-26427-0.

Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Ann Rheum Dis. 1992 Apr;51(4):461-4. doi: 10.1136/ard.51.4.461.

本文引用的文献

An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.

Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):26-9. doi: 10.1136/ard.41.suppl_1.26.

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

Ann Rheum Dis. 1984 Jun;43(3):398-401. doi: 10.1136/ard.43.3.398.

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1102-4. doi: 10.1136/bmj.287.6399.1102.

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1099-102. doi: 10.1136/bmj.287.6399.1099.

A biochemical assessment of sulphasalazine in rheumatoid arthritis.

J Rheumatol. 1982 Jan-Feb;9(1):36-45.

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

Ann Rheum Dis. 1985 Mar;44(3):194-8. doi: 10.1136/ard.44.3.194.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献